Updated Jul 16, 2026
Nixon Ronald T has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Nixon Ronald T is listed as a director of Sanara MedTech Inc. in SEC filings, with the most recent filing dated June 6, 2026. The available context explicitly identifies him as a director of the company; no other biographical details are provided in the SEC context. Based on the filing, he serves on the board and participates in governance of Sanara MedTech Inc.
| Role | Director, 10% Owner |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-06 | SMTI | Sanara MedTech Inc. | A — Grant or award | 4.2K | $0.00 |
Nixon Ronald T is listed as a director of Sanara MedTech Inc. in SEC filings, with the most recent filing dated June 6, 2026. The available context explicitly identifies him as a director of the company; no other biographical details are provided in the SEC context. Based on the filing, he serves on the board and participates in governance of Sanara MedTech Inc.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nixon Ronald T profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.